<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In an 18-month period seven children who were treated for a variety of neurological and non-<z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e>, and in whom the <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> or corticotrophin dosage was reduced, developed a syndrome indistinguishable from "benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>." The total duration and rate of reduction of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> dosage and perhaps an underlying susceptibility to cerebral <z:hpo ids='HP_0000969'>oedema</z:hpo> appear to be important factors in this syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>Usually patients can be treated without the need for special neuroradiological studies </plain></SENT>
<SENT sid="2" pm="."><plain>Possibly mild forms of this condition are not uncommon, but its pathogenesis is still uncertain </plain></SENT>
</text></document>